Thursday, February 12, 2026 | 08:31 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sanket Koul

Sanket Koul

Sanket Koul

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Email

Page 30 - Sanket Koul

Abbott launches 14-valent pneumococcal vaccine in India for children

Pneumococcal vaccines address infections caused by pneumococcal bacteria, including pneumonia, meningitis, and blood infections, collectively known as invasive pneumococcal disease

Abbott launches 14-valent pneumococcal vaccine in India for children
Updated On : 27 Nov 2024 | 6:44 PM IST

Dharmendra Pradhan launches Bharti Airtel Foundation's 'TheTeacherApp'

Platform includes 'free for life', CBSE-based resources to help educators meet evolving needs of education

Dharmendra Pradhan launches Bharti Airtel Foundation's 'TheTeacherApp'
Updated On : 25 Nov 2024 | 9:24 PM IST

Orchid Pharma to collaborate with hospital body CAHO to counter AMR

The collaboration aims to tackle AMR in India by focusing on tier 2 and tier 3 cities, bridging the gap between awareness and action, and ensuring sustainable AMR interventions

Orchid Pharma to collaborate with hospital body CAHO to counter AMR
Updated On : 25 Nov 2024 | 7:19 PM IST

UCL inks trilateral pact with AIIMS, IIT-D to scale up medtech innovation

Collaboration comes days after UCL signed agreement with IISc Bengaluru on clinical education

UCL inks trilateral pact with AIIMS, IIT-D to scale up medtech innovation
Updated On : 22 Nov 2024 | 9:29 PM IST

Small and medium hospitals market likely to reach Rs 5 trn by FY27: Report

Report suggests the sector still faces sustainability issues due to profit crunch, expanding competition from large chains

Small and medium hospitals market likely to reach Rs 5 trn by FY27: Report
Updated On : 22 Nov 2024 | 8:27 PM IST

Air pollution woes: Delhi hospitals see 50% jump in OPD visits, admissions

Jump in numbers comes as north Indian cities record AQI in excess of 350, Mumbai crosses 120

Air pollution woes: Delhi hospitals see 50% jump in OPD visits, admissions
Updated On : 19 Nov 2024 | 10:28 PM IST

India among our top three focus markets globally, says Pearson executive

The company is seeing a huge growth opportunity in English language learning, assessment and testing, and higher education

India among our top three focus markets globally, says Pearson executive
Updated On : 19 Nov 2024 | 5:15 PM IST

Glenmark Pharma Q2 profit rises on strong India business performance

The company also reported a 14.6 per cent rise in revenues in the European market to Rs 687.4 crore, while recording a 1.2 per cent revenue drop in the North America market

Glenmark Pharma Q2 profit rises on strong India business performance
Updated On : 14 Nov 2024 | 9:24 PM IST

Centre launches PAIR programme to enhance research in higher education

Each PAIR network will consist of one hub and up to seven spoke institutions

Centre launches PAIR programme to enhance research in higher education
Updated On : 14 Nov 2024 | 7:18 PM IST

Medanta Hospitals Q2 results: Net profit rises 4.5% to Rs 130 crore

The company's ARPOB per day rose to Rs 62,140 in Q2 FY25, a marginal growth of 1.9 per cent Y-o-Y compared to Rs 61,003 reported for the same period last year

Medanta Hospitals Q2 results: Net profit rises 4.5% to Rs 130 crore
Updated On : 14 Nov 2024 | 6:50 PM IST

India's import dependence on key pharma ingredients may reduce by half

Two newly inaugurated units will manufacture important molecules used in several common antibiotics

India's import dependence on key pharma ingredients may reduce by half
Updated On : 13 Nov 2024 | 11:01 PM IST

Zydus Lifesciences net profit up 14% on strong India, US formulations biz

The growth is attributed to strong performances across domestic and international formulations, and double-digit growth in the consumer wellness business

Zydus Lifesciences net profit up 14% on strong India, US formulations biz
Updated On : 12 Nov 2024 | 7:32 PM IST

Indian pharmaceutical market registers over 6% growth in October 2024

The value growth comes at a time when the IPM has registered a negative volume growth of 1.8 per cent

Indian pharmaceutical market registers over 6% growth in October 2024
Updated On : 11 Nov 2024 | 5:51 PM IST

Govt launches Rs 500 crore scheme to strengthen medical devices industry

This initial outlay of Rs 500 crore will be for three years, up to financial year 2026-27 (FY27), according to a government communication

Govt launches Rs 500 crore scheme to strengthen medical devices industry
Updated On : 09 Nov 2024 | 10:08 AM IST

Fortis Healthcare Q2 profit up 5%, revenue rises 12% on strong hospital biz

The company's revenue from operations rose to Rs 1,988 crore in Q2 FY25, a 12.3 per cent Y-o-Y increase from Rs 1,770 crore reported in Q2 FY24

Fortis Healthcare Q2 profit up 5%, revenue rises 12% on strong hospital biz
Updated On : 08 Nov 2024 | 8:42 PM IST

Yatharth Hospitals Q2FY25 results: Net profit up 12%, revenue rises 27%

The growth is attributed to higher occupancy rates and an increase in revenue per bed during the September quarter

Yatharth Hospitals Q2FY25 results: Net profit up 12%, revenue rises 27%
Updated On : 08 Nov 2024 | 2:11 PM IST

New launches likely to fuel domestic growth: JB Pharma CEO Nikhil Chopra

JB Pharma is on track to deliver strong results in the second half of financial year 2024-25

New launches likely to fuel domestic growth: JB Pharma CEO Nikhil Chopra
Updated On : 07 Nov 2024 | 11:45 PM IST

Cabinet approves PM-Vidyalaxmi to provide aid to meritorious students

Rs 3,600 crore outlay outlined for the scheme till FY31

Cabinet approves PM-Vidyalaxmi to provide aid to meritorious students
Updated On : 07 Nov 2024 | 12:04 AM IST

Medanta signs O&M pact for 750 bed hospital in Delhi, to invest Rs 600 cr

"The hospital is expected to commence operations in around four years, subject to necessary statutory and customary approvals"

Medanta signs O&M pact for 750 bed hospital in Delhi, to invest Rs 600 cr
Updated On : 06 Nov 2024 | 10:54 PM IST

JB Pharma Q2: PAT up 16%, revenue rises 13% over strong domestic growth

The company stated it has a strong order book for the remaining quarters of this financial year

JB Pharma Q2: PAT up 16%, revenue rises 13% over strong domestic growth
Updated On : 06 Nov 2024 | 7:56 PM IST